Collectively, the data confirmed that oncolytic ORFV-elevated GSDME plays a critical role in the process of ORFV-reshaped tumor immune microenvironment and ORFV-induced tumor suppression in immunologically “cold” tumors. The gene discussed is GSDME; the disease is neoplasm.